Establishes the mental health educational opportunity program and the mental health higher educational opportunity program to provide additional educational opportunities for students at certain universities and colleges in the state to enroll in academic programs that lead to a degree or degrees required for licensure in any of the mental health professions.
Relates to establishing an office of antibiotic-resistance control; establishes the antibiotics education fund; includes methicillin-resistant staphylococcus aureus (MRSA) and other antibiotic-resistant infections in the definition of airborne infectious disease.
This bill requires schools to develop policies for using FDA-registered airway clearance devices (portable medical tools for choking emergencies) and mandates training for school nurses and designated staff on their use. It allows school boards to reimburse training costs and protects schools from liability when volunteers provide emergency care using these devices, except as specified in public health law. The law directly affects all schools operating these devices, ensuring staff are trained and reducing legal barriers to emergency response. It takes effect 180 days after enactment, with rules needed for implementation before that date.
Requires notification by a prescriber or pharmacist of the substitution of one generic drug product for another generic drug product; requires both oral and written notification.
This bill amends New York's financial services law to explicitly include ambulance services to an emergency room as part of "emergency services" for surprise billing protections. It requires health insurance plans to cover non-participating ambulance providers' emergency services (including ambulance rides to the ER) without charging patients more out-of-pocket than they would with a participating provider. The law prohibits ambulance providers from billing patients for costs beyond standard copays, coinsurance, or deductibles. It also extends these protections to mobile crisis intervention services provided by licensed mental health or addiction services providers.
Establishes school based health centers to be organized through school, community, and health provider relationships and provide services in keeping with state and local laws and regulations, as well as established medical standards, and best practices.
S 138 establishes a "Medical Aid in Dying Act" for New York, allowing terminally ill patients (with decision-making capacity and a confirmed terminal illness expected to cause death within six months) to request and self-administer medication to end their life. Key provisions require patients to make an oral and written request, receive confirmation from two physicians (an attending physician and a consulting physician), and sign a witnessed written request with two non-related, non-beneficiary adults. The bill mandates patients be fully informed of alternatives like palliative care, outlines physician responsibilities, and includes requirements for documentation, safe medication disposal, and protections for healthcare providers.
This bill clarifies that medical marijuana, when dispensed under New York's medical marijuana program, must be treated as a "prescription drug" for coverage purposes under specific state programs, including Medicaid (title eleven of social services law), workers' compensation, and elder care programs. It requires these state-run programs to cover medical marijuana but explicitly states it does not mandate coverage by private insurers or health plans. The bill also adds a certification process for dispensaries to be recognized as medical assistance providers under state law. It applies to state programs only, not private insurance, and does not create new coverage requirements beyond the specified state-run systems.
This bill (A 7413) updates New York's process for determining a patient's incapacity to make healthcare decisions, specifically for life-sustaining treatment decisions. It requires an initial determination by a treating doctor, followed by a separate concurring determination by another qualified healthcare professional (like a nurse practitioner or specialist), to confirm the patient lacks capacity. The bill specifies different qualifications for the concurring reviewer based on whether incapacity stems from mental illness (requiring a psychiatrist) or developmental disability (requiring specialized training or experience). These determinations must be documented in the patient's medical record, and a patient's appointed healthcare agent cannot make the capacity determination. It directly affects hospitals, healthcare facilities, and medical staff involved in end-of-life care decisions.
This bill requires all health insurers in New York to cover long-term treatment for Lyme disease and other tick-borne illnesses. It mandates coverage for at least 30 days of intravenous antibiotics, 60 days of oral antibiotics, or a combination, plus additional treatment as recommended by a physician. The law applies to all individual health insurance policies, group plans, and medical expense corporations. It also expands workers' compensation to include Lyme disease as a covered disability and clarifies that workplace-related tick-borne illnesses qualify for benefits.
